Companies In the News
Authors:
Date:
PRNewswire: March 22, 2017 – JERUSALEM, Israel – Intec Pharma Ltd. (Nasdaq; TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ platform technology, announces the initiation of a phase I clinical trial of AP-CBD/THC, its…
Authors:
Date:
PRNewswire: March 14, 2017 – LUND, Sweden – Bonesupport AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease, or related surgery, announces that it has extended the term of its U.S. distribution agreement with Zimmer…
Authors:
Date:
PRNewswire: March 14, 2017 – SAN DIEGO, CA, U.S.A. – OncoSec Medical Incorporated (“OncoSec”) (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that they have entered into a technology access program (TAP) agreement with Inhibrx, LP, a privately…
Authors:
Date:
Business Wire: March 14, 2017 – BOSTON, MA, U.S.A., and MUMBAI, India – TA Associates, a leading global growth private equity firm, today announced it has completed an investment in Ideal Cures Private Limited, a supplier of ready-to-use coating products and excipients for tablets and capsules to…
Authors:
Date:
PRNewswire: November 3, 2016 – SAN DIEGO, CA, U.S.A. – Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has accepted Genentech’s Biologics License Application for a subcutaneous formulation of rituximab in multiple blood cancer indications…
Authors:
Date:
PRNewswire: November 3, 2016 – WARRINGTON, PA, U.S.A. – Windtree Therapeutics, Inc. (Nasdaq: WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, announced today that recently presented preclinical data at the 62nd Radiation Research…
